Beximco Pharma Signs MoU with NSU for Research Collaboration

Beximco Pharma & NSU sign MoU for research collaboration.

Dhaka, 07 May: Beximco Pharmaceuticals and the Department of Pharmaceutical Sciences of North South University (NSU) have entered a Memorandum of Understanding (MoU) aimed at fostering research, innovation, and career development in the pharmaceutical sector.

The MoU was signed on Monday ( 5 May 2025) by Mr. Rabbur Reza, Chief Operating Officer of Beximco Pharma, and Professor Abdul Hannan Chowdhury, Vice Chancellor of NSU, on behalf of their respective organizations.

Under this MoU, Beximco Pharma will provide financial support and access to world class research facilities to selected MPharm students from NSU, facilitating their thesis work on specific topics.

This collaboration underscores Beximco Pharma's commitment to nurturing future talent and advancing pharmaceutical research in Bangladesh.

“This partnership with North South University marks an important step in bridging the gap between industry and academia. At Beximco Pharma, being a socially responsible entity, we recognize the immense potential of industry-academia partnership in accelerating scientific research to meet the need of our patients. This will also help us build new capabilities to move up the pharmaceutical value chain”. — Rabbur Reza, Chief Operating Officer, Beximco Pharmaceuticals.

“We are deeply committed to fostering academic excellence through meaningful partnerships with industry. We believe this collaboration will bring together the best talents and help create an ecosystem of innovation in the country.” — Prof. Abdul Hannan Chowdhury, Vice Chancellor, North South University. – Press release